Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial

View/ Open
ICR Author
Author
Copland, M
Slade, D
McIlroy, G
Horne, G
Byrne, JL
Rothwell, K
Brock, K
De Lavallade, H
Craddock, C
Clark, RE
Smith, ML
Fletcher, R
Bishop, R
Milojkovic, D
Yap, C
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Clinical Trials & Statistics Unit
Language
eng
Date accepted
2021-12-11
Citation
The Lancet Haematology, 2021
Publisher
Elsevier BV